What is GLP1 Tracker?
Track your GLP-1 medications including Tirzepatide, Semaglutide, Ozempic, Wegovy, Mounjaro, and Zepbound. Monitor injection schedules, dosages, side effects, and weight loss progress with our comprehensive diabetes and weight management tracker.
Problem
Users manually track multiple aspects like injection schedules, dosages, side effects, and weight loss progress via spreadsheets, notes, or memory, leading to inconsistent monitoring and potential dosage errors.
Solution
A centralized platform to log injection schedules, track dosages, monitor side effects, and visualize weight loss progress over time. Users can set reminders, generate trends, and export data for healthcare reviews (e.g., tracking Tirzepatide dosage changes with weight correlation).
Customers
Patients using GLP-1 medications for diabetes or obesity management (demographics: adults aged 30-65, tech-savvy) and healthcare providers monitoring patients on GLP-1 therapies (e.g., endocrinologists, weight-loss specialists).
Unique Features
Specialized for GLP-1 medications with pre-loaded drug profiles, integration of clinical metrics (BMI, HbA1c), and symptom severity scoring tailored to common side effects of GLP-1 drugs like nausea or fatigue.
User Comments
Simplifies tracking for multiple medications
Helps identify patterns between dosage and side effects
Useful for sharing data with doctors
Weight trend visualization motivates progress
Needs mobile app integration
Traction
Launched 3 months ago; 1,200+ active users (70% patients, 30% providers), featured in ProductHunt’s Top 10 Healthcare Tools of May 2024 with 890+ upvotes.
Market Size
The global GLP-1 receptor agonist market is projected to reach $22 billion by 2030, with 45 million+ potential users in the US alone for diabetes and obesity treatment (IQVIA 2023 report).
